Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears
Longitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee injuries, particularly in athletes. The dis
| Condition(s) | Meniscus Tear, Meniscus Lesion, Fibrin Blood Clot, Knee Injuries |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Longitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee injuries, particularly in athletes. The displaced meniscal fragment can cause mechanical symptoms such as locking, clicking, or catching of the knee, as well as pain and swelling. If not properly treated, buckle-handle meniscal tears can lead to further complications, including chronic knee instability, increased risk of osteoarthritis, and persistent joint pain.Repairing a longitudinal meniscal tear offers several advantages over partial meniscectomy, particularly in preserving knee function and preventing long-term |
| Who can participate | Inclusion Criteria: * Presenting with a painful meniscus (lateral or medial) longitudinal tear * Being between the ages of 18 and 50 * Not having undergone surgery on the same knee before * Having an MRI taken at the end of the 1st year post-surgery Exclusion Criteria: * Having additional collateral ligamentous damage along with the meniscus tear (such as MCL or LCL) * Incomplete clinical scores at the end of the study * A history of previous surgery on the same knee * Having an active infection * Not having a control MRI at the end of the 1st year |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Lead sponsor | Ankara City Hospital Bilkent |
| Locations | Ankara, Turkey (Türkiye); Ankara, Turkey (Türkiye) |
| Start date | 2024-07-25 |
| NCT ID | NCT06541756 |
| Official listing | https://clinicaltrials.gov/study/NCT06541756 |